Treatment options for alcoholic and non-alcoholic fatty liver disease: A review

Acetyl-coenzyme A carboxylase inhibition reduces de novo lipogenesis in overweight male subjects: A randomized, double-blind, crossover study

(2017) Kathryn Stiede et al.   HEPATOLOGY

The FXR agonist PX20606 ameliorates portal hypertension by targeting vascular remodelling and sinusoidal dysfunction

(2017) Philipp Schwabl et al.   JOURNAL OF HEPATOLOGY

Treatment with the natural FXR agonist chenodeoxycholic acid reduces clearance of plasma LDL whilst decreasing circulating PCSK9, lipoprotein(a) and apolipoprotein C-III

(2017) M. Ghosh Laskar et al.   JOURNAL OF INTERNAL MEDICINE

Sitagliptin in patients with non-alcoholic steatohepatitis: A randomized, placebo-controlled trial

(2017) Tisha R Joy et al.   WORLD JOURNAL OF GASTROENTEROLOGY

BAR502, a dual FXR and GPBAR1 agonist, promotes browning of white adipose tissue and reverses liver steatosis and fibrosis

(2017) Adriana Carino et al.   Scientific Reports

The Role of Nuclear Receptors in the Pathophysiology, Natural Course, and Drug Treatment of NAFLD in Humans

(2016) Stefano Ballestri et al.   ADVANCES IN THERAPY

Efficacy and safety study of cenicriviroc for the treatment of non-alcoholic steatohepatitis in adult subjects with liver fibrosis: CENTAUR Phase 2b study design

(2016) Scott Friedman et al.   Contemporary Clinical Trials

HepaticDPP4DNA Methylation Associates With Fatty Liver

(2016) Christian Baumeier et al.   DIABETES

Effects of obeticholic acid on lipoprotein metabolism in healthy volunteers

(2016) R. Pencek et al.   DIABETES OBESITY & METABOLISM

Lifestyle and Dietary Interventions in the Management of Nonalcoholic Fatty Liver Disease

(2016) William N. Hannah et al.   DIGESTIVE DISEASES AND SCIENCES

p38  and p38  reprogram liver metabolism by modulating neutrophil infiltration

(2016) B. Gonzalez-Teran et al.   EMBO JOURNAL

Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

(2016) Vlad Ratziu et al.   GASTROENTEROLOGY

Hepatic-specific PPARα-FGF21 action in NAFLD

(2016) Elena Piccinin et al.   GUT

Liver PPARα is crucial for whole-body fatty acid homeostasis and is protective against NAFLD

(2016) Alexandra Montagner et al.   GUT

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

(2016) Zobair M. Younossi et al.   HEPATOLOGY

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis

(2016) Stefano Ballestri et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis

(2016) Mei Xiang et al.   JOURNAL OF HEPATOLOGY

Glucagon-like peptide 1 decreases lipotoxicity in non-alcoholic steatohepatitis

(2016) Matthew J. Armstrong et al.   JOURNAL OF HEPATOLOGY

Obeticholic acid reduces bacterial translocation and inhibits intestinal inflammation in cirrhotic rats

(2016) María Úbeda et al.   JOURNAL OF HEPATOLOGY

Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial

(2016) Jeffrey Cui et al.   JOURNAL OF HEPATOLOGY

Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study

(2016) Matthew James Armstrong et al.   LANCET

Acetyl-CoA carboxylase inhibition by ND-630 reduces hepatic steatosis, improves insulin sensitivity, and modulates dyslipidemia in rats

(2016) Geraldine Harriman et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Alcoholic liver disease and hepatitis C virus infection

(2016) Ignacio Novo-Veleiro   WORLD JOURNAL OF GASTROENTEROLOGY

Emerging role of obeticholic acid in the management of nonalcoholic fatty liver disease

(2016) Evangelia Makri et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Fatty liver is associated with an increased risk of diabetes and cardiovascular disease - Evidence from three different disease models: NAFLD, HCV and HIV

(2016) Amedeo Lonardo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis

(2016) Len Verbeke et al.   Scientific Reports

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

(2016) Amrita Ostawal et al.   Diabetes Therapy

Fibroblast Growth Factor Signaling in Metabolic Regulation

(2016) Vera J. M. Nies et al.   Frontiers in Endocrinology

Clinical Effectiveness of Liraglutide in Type 2 Diabetes Treatment in the Real-World Setting: A Systematic Literature Review

(2016) Amrita Ostawal et al.   Diabetes Therapy

Antifibrotic Effects of the Dual CCR2/CCR5 Antagonist Cenicriviroc in Animal Models of Liver and Kidney Fibrosis

(2016) Eric Lefebvre et al.   PLoS One

An overview of the genetics, mechanisms and management of NAFLD and ALD

(2015) R. J. Rowell et al.   CLINICAL MEDICINE

Diagnosis and treatment of nutritional deficiencies in alcoholic liver disease: Overview of available evidence and open issues

(2015) Roberta Elisa Rossi et al.   DIGESTIVE AND LIVER DISEASE

Systemic inflammatory response and serum lipopolysaccharide levels predict multiple organ failure and death in alcoholic hepatitis

(2015) Javier Michelena et al.   HEPATOLOGY

Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: A systematic review and network meta-analysis

(2015) Siddharth Singh et al.   HEPATOLOGY

P0932 : Treatment with NGM282 significantly improves liver histopathology in a mouse model of non-alcoholic steatohepatitis (NASH)

(2015) J. Luo et al.   JOURNAL OF HEPATOLOGY

LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases

(2015) M. Shiffman et al.   JOURNAL OF HEPATOLOGY

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

Nutritional therapy in cirrhosis or alcoholic hepatitis: a systematic review and meta-analysis

(2015) Annette D. Fialla et al.   LIVER INTERNATIONAL

Prednisolone or Pentoxifylline for Alcoholic Hepatitis

(2015) Mark R. Thursz et al.   NEW ENGLAND JOURNAL OF MEDICINE

The Genetics of Nonalcoholic Fatty Liver Disease: Spotlight on PNPLA3 and TM6SF2

(2015) Christopher Day et al.   SEMINARS IN LIVER DISEASE

Metadoxine improves the three- and six-month survival rates in patients with severe alcoholic hepatitis

(2015) Fátima Higuera-de la Tijera   WORLD JOURNAL OF GASTROENTEROLOGY

Research Perspectives on the Regulation and Physiological Functions of FGF21 and its Association with NAFLD

(2015) Takeshi Inagaki   Frontiers in Endocrinology

Systematic review with meta-analysis: the I148M variant of patatin-like phospholipase domain-containing 3 gene (PNPLA3) is significantly associated with alcoholic liver cirrhosis

(2014) A.-J. Chamorro et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Pharmacotherapy for alcoholic patients with alcoholic liver disease

(2014) Cynthia L. Vuittonet et al.   AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY

Human lysyl oxidase-like 2

(2014) Hee-Jung Moon et al.   BIOORGANIC CHEMISTRY

The Fatty Acid–Bile Acid Conjugate Aramchol Reduces Liver Fat Content in Patients With Nonalcoholic Fatty Liver Disease

(2014) Rifaat Safadi et al.   Clinical Gastroenterology and Hepatology

Pharmacological Approaches to Reducing Craving in Patients with Alcohol Use Disorders

(2014) Carolina L. Haass-Koffler et al.   CNS DRUGS

Knocking on FXR's Door:The "Hammerhead"-Structure Series of FXRs Agonists - Amphiphilic Isoxazoles with Potent In Vitro and In Vivo Activities

(2014) Christian Gege et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Pentoxifylline for the treatment of nonalcoholic fatty liver disease

(2014) Tao Zeng et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

CCL20 mediates lipopolysaccharide induced liver injury and is a potential driver of inflammation and fibrosis in alcoholic hepatitis

(2014) Silvia Affò et al.   GUT

Chemokines and alcoholic hepatitis: are chemokines good therapeutic targets?

(2014) Bin Gao et al.   GUT

Potential role of cytokine CCL20 in alcoholic hepatitis

(2014) Isobel Leake   Nature Reviews Gastroenterology & Hepatology

TNF and MAP kinase signalling pathways

(2014) Guadalupe Sabio et al.   SEMINARS IN IMMUNOLOGY

Acute alcoholic hepatitis, end stage alcoholic liver disease and liver transplantation: An Italian position statement

(2014) Gianni Testino   WORLD JOURNAL OF GASTROENTEROLOGY

Effects of pentoxifylline on nonalcoholic fatty liver disease: A meta-analysis

(2014) Juan Du   WORLD JOURNAL OF GASTROENTEROLOGY

Management of Alcohol Dependence in Patients with Liver Disease

(2013) Giovanni Addolorato et al.   CNS DRUGS

Resveratrol modulates autophagy and NF-κB activity in a murine model for treating non-alcoholic fatty liver disease

(2013) Lake Li et al.   FOOD AND CHEMICAL TOXICOLOGY

Efficacy and Safety of the Farnesoid X Receptor Agonist Obeticholic Acid in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease

(2013) Sunder Mudaliar et al.   GASTROENTEROLOGY

Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis

(2013) Oriol Morales-Ibanez et al.   HEPATOLOGY

Hepatoprotective effects of the dual peroxisome proliferator-activated receptor alpha/delta agonist, GFT505, in rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2013) Bart Staels et al.   HEPATOLOGY

Association between thePNPLA3(rs738409 C>G) variant and hepatocellular carcinoma: Evidence from a meta-analysis of individual participant data

(2013) Eric Trépo et al.   HEPATOLOGY

Prednisolone With vs Without Pentoxifylline and Survival of Patients With Severe Alcoholic Hepatitis

(2013) Philippe Mathurin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Stem cell therapies for liver failure and cirrhosis

(2013) Zheng Zhang et al.   JOURNAL OF HEPATOLOGY

Histological improvement following administration of autologous bone marrow-derived mesenchymal stem cells for alcoholic cirrhosis: a pilot study

(2013) Yoon Ok Jang et al.   LIVER INTERNATIONAL

SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease

(2013) Yasar Colak et al.   MEDICAL SCIENCE MONITOR

Highest Frequencies of Interleukin-22-Producing T Helper Cells in Alcoholic Hepatitis Patients with a Favourable Short-Term Course

(2013) Sidsel Støy et al.   PLoS One

Therapy of Experimental NASH and Fibrosis with Galectin Inhibitors

(2013) Peter G. Traber et al.   PLoS One

Steroids or pentoxifylline for alcoholic hepatitis (STOPAH): study protocol for a randomised controlled trial

(2013) Ewan Forrest et al.   Trials

Dietary Omega-3 Fatty Acid Deficiency and High Fructose Intake in the Development of Metabolic Syndrome, Brain Metabolic Abnormalities, and Non-Alcoholic Fatty Liver Disease

(2013) Artemis Simopoulos   Nutrients

The Diagnosis and Management of Non-alcoholic Fatty Liver Disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology and the American Gastroenterological Association

(2012) Naga Chalasani et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Mesenchymal-Stem-Cell-Induced Immunoregulation Involves FAS-Ligand-/FAS-Mediated T Cell Apoptosis

(2012) Kentaro Akiyama et al.   Cell Stem Cell

Comment to “Liver transplantation for patients with alcoholic liver disease: An open question”

(2012) Gianni Testino et al.   DIGESTIVE AND LIVER DISEASE

Corticosteroid Plus Pentoxifylline Is Not Better than Corticosteroid Alone for Improving Survival in Severe Alcoholic Hepatitis (COPE Trial)

(2012) Sandeep Singh Sidhu et al.   DIGESTIVE DISEASES AND SCIENCES

Seven sirtuins for seven deadly diseases ofaging

(2012) Brian J. Morris   FREE RADICAL BIOLOGY AND MEDICINE

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

(2012) Tomonori Aoyama et al.   HEPATOLOGY

Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism

(2012) Claudia O. Zein et al.   HEPATOLOGY

Eukaryotic elongation factor 2 controls TNF-α translation in LPS-induced hepatitis

(2012) Bárbara González-Terán et al.   JOURNAL OF CLINICAL INVESTIGATION

Malonyl-CoA: the regulator of fatty acid synthesis and oxidation

(2012) Daniel W. Foster   JOURNAL OF CLINICAL INVESTIGATION

The Evolution and Treatment of Korsakoff's Syndrome

(2012) A. D. Thomson et al.   NEUROPSYCHOLOGY REVIEW

p38  and p38  kinases regulate the Toll-like receptor 4 (TLR4)-induced cytokine production by controlling ERK1/2 protein kinase pathway activation

(2012) A. Risco et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Wernicke-Korsakoff-Syndrome: Under-Recognized and Under-Treated

(2012) Elie Isenberg-Grzeda et al.   PSYCHOSOMATICS

Holotranscobalamin Is a Useful Marker of Vitamin B12 Deficiency in Alcoholics

(2012) Alberto Fragasso et al.   TheScientificWorldJOURNAL

Nonalcoholic fatty liver disease and bariatric surgery

(2012) Sindu Stephen et al.   Expert Review of Gastroenterology & Hepatology

Dose-Response Effect of Baclofen in Reducing Daily Alcohol Intake in Alcohol Dependence: Secondary Analysis of a Randomized, Double-Blind, Placebo-Controlled Trial

(2011) G. Addolorato et al.   ALCOHOL AND ALCOHOLISM

Acamprosate for Alcohol Dependence: A Sex-Specific Meta-Analysis Based on Individual Patient Data

(2011) Barbara J Mason et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Management of Alcoholic Liver Disease: An Update

(2011) David Kershenobich et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Alcoholic Liver Disease and Malnutrition

(2011) Craig J. McClain et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

When Galectins Recognize Glycans: From Biochemistry to Physiology and Back Again

(2011) Santiago Di Lella et al.   BIOCHEMISTRY

FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents

(2011) J. Mu et al.   DIABETES

Bifidobacterium longum with Fructo-Oligosaccharides in Patients with Non Alcoholic Steatohepatitis

(2011) Michele Malaguarnera et al.   DIGESTIVE DISEASES AND SCIENCES

Protein energy malnutrition predicts complications in liver cirrhosis

(2011) Ellen J. Huisman et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Sitagliptin as a Novel Treatment Agent for Non-Alcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus

(2011) Tomoyuki Iwasaki et al.   HEPATO-GASTROENTEROLOGY

The nicotinamide adenine dinucleotide phosphate oxidase (NOX) homologues NOX1 and NOX2/gp91phox mediate hepatic fibrosis in mice

(2011) Yong-Han Paik et al.   HEPATOLOGY

Pentoxifylline improves nonalcoholic steatohepatitis: A randomized placebo-controlled trial

(2011) Claudia O. Zein et al.   HEPATOLOGY

Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice

(2011) Alexandre Louvet et al.   HEPATOLOGY

Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease

(2011) Silvia Sookoian et al.   HEPATOLOGY

Alcoholic liver disease: pathogenesis and new targets for therapy

(2011) José Altamirano et al.   Nature Reviews Gastroenterology & Hepatology

Early Liver Transplantation for Severe Alcoholic Hepatitis

(2011) Philippe Mathurin et al.   NEW ENGLAND JOURNAL OF MEDICINE

Fish oil improves lipid metabolism and ameliorates inflammation in patients with metabolic syndrome: Impact of nonalcoholic fatty liver disease

(2011) Mohammed M. H. Al-Gayyar et al.   PHARMACEUTICAL BIOLOGY

Systematic review: glucocorticosteroids for alcoholic hepatitis - a Cochrane Hepato-Biliary Group systematic review with meta-analyses and trial sequential analyses of randomized clinical trials

(2010) A. RAMBALDI et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

EFNS guidelines for diagnosis, therapy and prevention of Wernicke encephalopathy

(2010) R. Galvin et al.   EUROPEAN JOURNAL OF NEUROLOGY

Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data

(2010) P. Mathurin et al.   GUT

Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: Role of signal transducer and activator of transcription 3

(2010) Sung Hwan Ki et al.   HEPATOLOGY

A meta-analysis of randomized trials for the treatment of nonalcoholic fatty liver disease

(2010) Giovanni Musso et al.   HEPATOLOGY

Endocannabinoids in liver disease

(2010) Joseph Tam et al.   HEPATOLOGY

Prevalence and Trends in Obesity Among US Adults, 1999-2008

(2010) Katherine M. Flegal   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

An overview of the metabolic effects of rimonabant in randomized controlled trials: potential for other cannabinoid 1 receptor blockers in obesity

(2010) F. D. Christopoulou et al.   JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS

Impact of pan-caspase inhibition in animal models of established steatosis and non-alcoholic steatohepatitis

(2010) Quentin M. Anstee et al.   JOURNAL OF HEPATOLOGY

De novo malignancies following liver transplantation: Impact and recommendations

(2010) J. Ignacio Herrero   LIVER TRANSPLANTATION

Allosteric inhibition of lysyl oxidase–like-2 impedes the development of a pathologic microenvironment

(2010) Vivian Barry-Hamilton et al.   NATURE MEDICINE

Serum Dipeptidyl Peptidase-4 Activity in Insulin Resistant Patients with Non-Alcoholic Fatty Liver Disease: A Novel Liver Disease Biomarker

(2010) Gábor Firneisz et al.   PLoS One

Effects of AIN457, a Fully Human Antibody to Interleukin-17A, on Psoriasis, Rheumatoid Arthritis, and Uveitis

(2010) W. Hueber et al.   Science Translational Medicine

cJun NH2-terminal kinase 1 (JNK1): roles in metabolic regulation of insulin resistance

(2010) Guadalupe Sabio et al.   TRENDS IN BIOCHEMICAL SCIENCES

Understanding and Treating Patients With Alcoholic Cirrhosis: An Update

(2009) Giovanni Addolorato et al.   ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH

Intestinal decontamination improves liver haemodynamics in patients with alcohol-related decompensated cirrhosis

(2009) J. VLACHOGIANNAKOS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)

(2009) P. Burra et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Infection in Patients With Severe Alcoholic Hepatitis Treated With Steroids: Early Response to Therapy Is the Key Factor

(2009) Alexandre Louvet et al.   GASTROENTEROLOGY

Hepatic Expression of CXC Chemokines Predicts Portal Hypertension and Survival in Patients With Alcoholic Hepatitis

(2009) Marlene Dominguez et al.   GASTROENTEROLOGY

Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease

(2009) Luca Miele et al.   HEPATOLOGY

Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis

(2009) Rafal P. Witek et al.   HEPATOLOGY

CCR2 promotes hepatic fibrosis in mice

(2009) Ekihiro Seki et al.   HEPATOLOGY

Alcoholic liver disease

(2009) Robert S. O'Shea et al.   HEPATOLOGY

The regulation of inflammation by galectin-3

(2009) Neil C. Henderson et al.   IMMUNOLOGICAL REVIEWS

FGF19-induced Hepatocyte Proliferation Is Mediated through FGFR4 Activation

(2009) Xinle Wu et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

(2009) Jürgen Rehm et al.   LANCET

Role of Muscle c-Jun NH2-Terminal Kinase 1 in Obesity-Induced Insulin Resistance

(2009) G. Sabio et al.   MOLECULAR AND CELLULAR BIOLOGY

Controversies in the Management of Alcoholic Liver Disease

(2009) Hui-Hui Tan et al.   MOUNT SINAI JOURNAL OF MEDICINE

Alcoholic Hepatitis

(2009) Michael R. Lucey et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metformin in patients with non-alcoholic fatty liver disease: A randomized, controlled trial

(2009) John Willy Haukeland et al.   SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY

Alcoholic Liver Disease and Methionine Metabolism

(2009) Kusum Kharbanda   SEMINARS IN LIVER DISEASE

Pentoxifylline: A first line treatment option for severe alcoholic hepatitis and hepatorenal syndrome?

(2009) Stelios F Assimakopoulos et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Pentoxifylline versus prednisolone for severe alcoholic hepatitis: A randomized controlled trial

(2009) Binay Krishna De et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Probiotics restore bowel flora and improve liver enzymes in human alcohol-induced liver injury: a pilot study

(2008) Irina A. Kirpich et al.   ALCOHOL

Clinical trial: pilot study of metformin for the treatment of non-alcoholic steatohepatitis

(2008) R. LOOMBA et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Alleviation of acute ethanol-induced liver injury and impaired metabolomics of S-containing substances by betaine supplementation

(2008) Sun J. Kim et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Paracrine Activation of Hepatic CB1 Receptors by Stellate Cell-Derived Endocannabinoids Mediates Alcoholic Fatty Liver

(2008) Won-il Jeong et al.   Cell Metabolism

Osteopontin: Role in immune regulation and stress responses

(2008) Kathryn X. Wang et al.   CYTOKINE & GROWTH FACTOR REVIEWS

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice

(2008) Shuqin Zheng et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Galectins: structure, function and therapeutic potential

(2008) Ri-Yao Yang et al.   EXPERT REVIEWS IN MOLECULAR MEDICINE

Cell Type–Dependent Pro- and Anti-Inflammatory Role of Signal Transducer and Activator of Transcription 3 in Alcoholic Liver Injury

(2008) Norio Horiguchi et al.   GASTROENTEROLOGY

Rosiglitazone for Nonalcoholic Steatohepatitis: One-Year Results of the Randomized Placebo-Controlled Fatty Liver Improvement With Rosiglitazone Therapy (FLIRT) Trial

(2008) Vlad Ratziu et al.   GASTROENTEROLOGY

Randomized, Placebo-Controlled Trial of Pioglitazone in Nondiabetic Subjects With Nonalcoholic Steatohepatitis

(2008) Guruprasad P. Aithal et al.   GASTROENTEROLOGY

Stem Cell Therapy for Liver Disease: Parameters Governing the Success of Using Bone Marrow Mesenchymal Stem Cells

(2008) Tom K. Kuo et al.   GASTROENTEROLOGY

Hepatocyte differentiation of mesenchymal stem cells from human adipose tissue in vitro promotes hepatic integration in vivo

(2008) H Aurich et al.   GUT

The interleukin-17 pathway is involved in human alcoholic liver disease

(2008) Arnaud Lemmers et al.   HEPATOLOGY

Effect of probiotic treatment on deranged neutrophil function and cytokine responses in patients with compensated alcoholic cirrhosis

(2008) Vanessa Stadlbauer et al.   JOURNAL OF HEPATOLOGY

Fructose consumption as a risk factor for non-alcoholic fatty liver disease

(2008) Xiaosen Ouyang et al.   JOURNAL OF HEPATOLOGY

Health care costs of persons with newly diagnosed hepatitis C virus: a population-based, observational study

(2008) Thu-Ha Nguyen et al.   JOURNAL OF VIRAL HEPATITIS

Meta-analysis of risk for relapse to substance use after transplantation of the liver or other solid organs

(2008) Mary Amanda Dew et al.   LIVER TRANSPLANTATION

Endocannabinoids and Liver Disease. I. Endocannabinoids and their receptors in the liver

(2007) A. Mallat et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY